Evidence map›Paper›PMID 24936976›Full record

ArticlePloS one2014

Standardized metadata for human pathogen/vector genomic sequences.

Vivien G Dugan, Scott J Emrich, Gloria I Giraldo-Calderón, Omar S Harb, Ruchi M Newman, Brett E Pickett, Lynn M Schriml, Timothy B Stockwell, Christian J Stoeckert, Dan E Sullivan and 48 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Methods for Genomic Epidemiology of Bacterial Pathogens: Example Salmonella.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors.

Vivien G DuganJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America; National Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
Scott J EmrichUniversity of Notre Dame, Notre Dame, Indiana, United States of America.
Gloria I Giraldo-CalderónUniversity of Notre Dame, Notre Dame, Indiana, United States of America.
Omar S HarbUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Ruchi M NewmanBroad Institute, Cambridge, Massachusetts, United States of America.
Brett E PickettJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Lynn M SchrimlInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Timothy B StockwellJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Christian J StoeckertUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Dan E SullivanCyberinfrastructure Division, Virginia Bioinformatics Institute, Blacksburg, Virginia, United States of America.
Indresh SinghJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Doyle V WardBroad Institute, Cambridge, Massachusetts, United States of America.
Alison YaoNational Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
Jie ZhengUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Tanya BarrettNational Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, United States of America.
Bruce BirrenBroad Institute, Cambridge, Massachusetts, United States of America.
Lauren BrinkacJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Vincent M BrunoInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Elizabet CalerJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Sinéad ChapmanBroad Institute, Cambridge, Massachusetts, United States of America.
Frank H CollinsUniversity of Notre Dame, Notre Dame, Indiana, United States of America.
Christina A CuomoBroad Institute, Cambridge, Massachusetts, United States of America.
Valentina Di FrancescoNational Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
Scott DurkinJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Mark EppingerInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Michael FeldgardenBroad Institute, Cambridge, Massachusetts, United States of America.
Claire FraserInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
W Florian FrickeInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Maria GiovanniNational Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
Matthew R HennBroad Institute, Cambridge, Massachusetts, United States of America.
Erin HineInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Julie Dunning HotoppInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Ilene Karsch-MizrachiNational Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, United States of America.
Jessica C KissingerUniversity of Georgia, Athens, Georgia, United States of America.
Eun Mi LeeNational Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
Punam MathurNational Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
Emmanuel F MongodinInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Cheryl I MurphyBroad Institute, Cambridge, Massachusetts, United States of America.
Garry MyersInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Daniel E NeafseyBroad Institute, Cambridge, Massachusetts, United States of America.
Karen E NelsonJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
William C NiermanJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Julia PuzakKelly Government Solutions, Rockville, Maryland, United States of America.
David RaskoInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
David S RoosUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Lisa SadzewiczInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Joana C SilvaInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Bruno SobralCyberinfrastructure Division, Virginia Bioinformatics Institute, Blacksburg, Virginia, United States of America.
R Burke SquiresNational Institute of Allergy and Infectious Diseases, Rockville, Maryland, United States of America.
Rick L StevensArgonne National Laboratory, Lemont, Illinois, United States of America.
Luke TallonInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Herve TettelinInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
David WentworthJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Owen WhiteInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Rebecca WillCyberinfrastructure Division, Virginia Bioinformatics Institute, Blacksburg, Virginia, United States of America.
Jennifer WortmanBroad Institute, Cambridge, Massachusetts, United States of America.
Yun ZhangJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America.
Richard H ScheuermannJ. Craig Venter Institute, Rockville, Maryland, and La Jolla, California, United States of America; Department of Pathology, University of California San Diego, San Diego, California, United States of America.

Funding

National Biomedical Information ServicesZIHLM200888 · NLM · NATIONAL LIBRARY OF MEDICINE · PI PALTOO, DINA · 2009 to 2025
$5200.7M
Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI NEAFSEY, DANIEL E · 2014 to 2024
$66.5M
Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DUNNING HOTOPP, JULIE · 2014 to 2023
$36.5M
Integrative tools for protozoan parasite researchR01GM093132 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI STOECKERT, CHRISTIAN J. · 2010 to 2012
$1.1M
Intramural NIH HHSNIAID NIH HHS HHSN272200900007CNIAID NIH HHS HHSN272200900009CNIAID NIH HHS HHSN272200900018CNIAID NIH HHS HHSN272200900038CNIAID NIH HHS HHSN272200900039CNIAID NIH HHS HHSN272200900040CNIAID NIH HHS HHSN272200900041CNIGMS NIH HHS R01 GM093132NIGMS NIH HHS R01GM093132PHS HHS HHSN266200400041C
6 · The paper itself

Abstract

High throughput sequencing has accelerated the determination of genome sequences for thousands of human infectious disease pathogens and dozens of their vectors. The scale and scope of these data are enabling genotype-phenotype association studies to identify genetic determinants of pathogen virulence and drug/insecticide resistance, and phylogenetic studies to track the origin and spread of disease outbreaks. To maximize the utility of genomic sequences for these purposes, it is essential that metadata about the pathogen/vector isolate characteristics be collected and made available in organized, clear, and consistent formats. Here we report the development of the GSCID/BRC Project and Sample Application Standard, developed by representatives of the Genome Sequencing Centers for Infectious Diseases (GSCIDs), the Bioinformatics Resource Centers (BRCs) for Infectious Diseases, and the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), informed by interactions with numerous collaborating scientists. It includes mapping to terms from other data standards initiatives, including the Genomic Standards Consortium's minimal information (MIxS) and NCBI's BioSample/BioProjects checklists and the Ontology for Biomedical Investigations (OBI). The standard includes data fields about characteristics of the organism or environmental source of the specimen, spatial-temporal information about the specimen isolation event, phenotypic characteristics of the pathogen/vector isolated, and project leadership and support. By modeling metadata fields into an ontology-based semantic framework and reusing existing ontologies and minimum information checklists, the application standard can be extended to support additional project-specific data fields and integrated with other data represented with comparable standards. The use of this metadata standard by all ongoing and future GSCID sequencing projects will provide a consistent representation of these data in the BRC resources and other repositories that leverage these data, allowing investigators to identify relevant genomic sequences and perform comparative genomics analyses that are both statistically meaningful and biologically relevant.

Indexed as

AnimalsCommunicable DiseasesDatabases, GeneticDatasets as TopicDisease VectorsGene OntologyGenomeHumansReference StandardsSequence Analysis, DNAVirulence

Identifiers

PMID24936976
PMCPMC4061050

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.